Holdings

Symbol Grade Price % Change Allocation
0QIU B -0.95 5.34
0QCV D 0.43 4.13
AZN A -0.13 2.68
0QLR A 0.00 2.55
0QOK F 0.00 2.30
0Q1N F 3.11 2.01
0R29 D -0.18 1.80
0Y6X D 0.91 1.49
0QZU C 1.60 1.38
0A77 A 0.31 1.36
0HRS F -17.85 1.32
0HOY A 0.52 1.29
GSK A 0.50 1.14
0M3Q D -0.85 1.00
0J8P F -5.99 0.58
0QNO B -1.01 0.57
0HAV C -0.03 0.55
0HF3 B -3.59 0.53
0A45 B -2.14 0.44
0R1B C 0.36 0.40
0KW4 A 0.94 0.37
0HTG D -0.29 0.35
0QW0 F 0.00 0.30
0O14 F 0.00 0.29
0J8Z F -0.37 0.28
0J5Q C 0.10 0.24
0QMV D 0.00 0.23
0QBO D -1.52 0.22
0LNG A 0.00 0.20
0NZT A 0.00 0.20
0QPY C 0.00 0.19
0OO9 A 0.00 0.15
SN D 1.19 0.14
0LJL A 0.02 0.14
0L3C F -1.77 0.13
0RLT A 0.00 0.12
0QOK F 0.00 0.11
0MH6 A 0.00 0.06
0N61 C 0.00 0.06
0GZV B 0.00 0.06
0RGT D -4.00 0.06
0DHC D 0.00 0.06
HIK C 0.10 0.05
0M2O D 0.00 0.05
0QND B 0.00 0.04

Recent News for db x-trackers MSCI World Health Care Index UCITS ETF & its Holdings

Date Stock Title
May 2 GSK GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 1 AZN AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
May 1 GSK GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
May 1 GSK GSK raises profit guidance as vaccine demand grows
May 1 GSK GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
May 1 AZN AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio
May 1 GSK Trending tickers: Amazon, AMD, GSK and Aston Martin
May 1 GSK GSK Lifts Guidance After Turnover Beats Expectations
Apr 30 GSK Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
Apr 30 AZN AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
Apr 29 AZN AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
Apr 29 AZN AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Apr 29 AZN AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement
Apr 29 AZN AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
Apr 29 AZN ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow
Apr 27 AZN AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Apr 26 AZN Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Apr 26 AZN Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Apr 25 AZN AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
The aim is for the investment to reflect the performance of the MSCI World Health Care Total Return Net Index (Index) which is designed to reflect the performance of the listed shares of certain companies from various developed countries. The shares are issued by companies in the health care sector. A company’s weighting in the Index depends on its relative size based on the combined value of a company’s readily available shares as compared to other companies. The Index is calculated on a total return net basis which means that all dividends and distributions by the companies are reinvested in the shares after tax. The Index is reviewed and rebalanced at least quarterly. The Fund will attempt to replicate the Index by buying a substantial number of the shares in the Index in the same proportion as the Index as determined by the Sub-Portfolio Manager of the Fund which is Deutsche Asset Management (UK) Limited.
Exchange Traded Fund Dividend Health Asset Management Dividends MSCI World Health Care
Back to the Main XDWH Page...